CIK: 0001542339
Total reported value
$250.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABMDEUR | Abiomed INC | Stock-Other | 37.57% | — | — | |
| 2 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 21.92% | — | — | |
| 3 | AXGN | Axogen INC | Stock-Other | 14.72% | — | — | |
| 4 | ✓ | Corium Intl INC | Stock-Other | 12.62% | — | — | |
| 5 | ✓ | Entellus Medical INC | Stock-Other | 9.68% | — | — | |
| 6 | ✓ | Endologix INC | Stock-Other | 2.12% | — | — | |
| 7 | MNOV | Medicinova INC | Stock-Other | 1.11% | +0.14% | — | |
| 8 | ACUR | Acura Pharmaceuticals INC | Stock-Other | 0.20% | — | — | |
| 9 | ✓ | Catalyst Biosciences INC | Stock-Other | 0.07% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Corium Intl INC | +3.7% | — | Unchanged |
| 2 | AXGN | Axogen INC | +3.1% | — | Unchanged |
| 3 | RVNCEUR | Revance Therapeutics INC | +0.1% | — | Unchanged |
| 4 | ACUR | Acura Pharmaceuticals INC | -0.1% | — | Unchanged |
| 5 | ✓ | Catalyst Biosciences INC | -0.1% | — | Unchanged |
| 6 | MNOV | Medicinova INC | -0.5% | — | Unchanged |
| 7 | ✓ | Entellus Medical INC | -0.5% | — | Unchanged |
| 8 | ✓ | Endologix INC | -1.2% | — | Unchanged |
| 9 | ABMDEUR | Abiomed INC | -3.9% | — | Unchanged |
| 10 | LGND | Ligand Pharmaceuticals | — | EXIT | Sold out |